Increase of liver stiffness and altered bile acid metabolism after triple CFTR modulator initiation in children and young adults with cystic fibrosis (2023) Schnell A, Jüngert JM, Klett D, Hober H, Kaiser N, Ruppel R, Geppert A, et al. Journal article Impact on follow-up strategies in patients with primary sclerosing cholangitis (2022) Bergquist A, Weismueller TJ, Levy C, Rupp C, Joshi D, Nayagam JS, Montano-Loza AJ, et al. Journal article Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis (2021) Efe C, Lammert C, Tascilar K, Dhanasekaran R, Ebik B, Higuera-De La Tijera F, Caliskan AR, et al. Journal article Anti-TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status (2021) Manka P, Sydor S, Wase N, Best J, Brandenburg M, Hellbeck A, Schänzer J, et al. Journal article Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis (2021) Kremer AE, Mayo MJ, Hirschfield G, Levy C, Bowlus CL, Jones DE, Steinberg A, et al. Journal article Role of fibroblast growth factor signalling in hepatic fibrosis (2021) Seitz T, Hellerbrand C Journal article, Review article Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension (2015) Hartl J, Dietrich P, Moleda L, Mueller-Schilling M, Wiest R Journal article Characterization and treatment of persistent hepatocellular secretory failure (2015) Van Dijk R, Kremer A, Smit W, Van Den Elzen B, Van Gulik T, Gouma D, Lameris JS, et al. Journal article